SHERLINE SAUVEUR: Open Payments
NPI 1023666138 · HAMPTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 20 payments from 10 companies in 2025. Trend: 2023 $211 · 2024 $39 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $198 |
| Inspire Medical Systems, Inc. | 1 | $136 |
| Merz Pharmaceuticals, LLC | 3 | $63 |
| Amneal Pharmaceuticals LLC | 3 | $58 |
| Lilly USA, LLC | 2 | $40 |
| Biogen, Inc. | 1 | $26 |
| MDD US Operations, LLC | 1 | $24 |
| Seqirus USA Inc | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: INGREZZA, INSPIRE, Xeomin, CREXONT, SKYCLARYS, Qelbree, ZEPBOUND, Fluad.
Industry payments across GA — which companies pay providers there.
